PubMed

Clinical trials in systemic sclerosis: lessons learned and outcomes.

Matucci-Cerinic M, Steen VD, Furst DE, Seibold JR.

Arthritis Res Ther. 2007;9 Suppl 2:S7. Review.PMID: 17767745 [PubMed - indexed for MEDLINE]Related articlesFree article

Therapeutic trials for systemic sclerosis: an update.

Sardana K, Garg VK.

Indian J Dermatol Venereol Leprol. 2008 Sep-Oct;74(5):436-46. Review.PMID: 19052400 [PubMed - indexed for MEDLINE]Related articlesFree article

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.

White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, LeRoy EC, Mitrane MP, Paulus HE, et al.

Arthritis Rheum. 1995 Mar;38(3):351-60.PMID: 7880189 [PubMed - indexed for MEDLINE]Related articles

Prevention of vascular damage in scleroderma with angiotensin-converting enzyme (ACE) inhibition.

Maddison P.

Rheumatology (Oxford). 2002 Sep;41(9):965-71. Review.PMID: 12209028 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical trial design in systemic lupus erythematosus.

Dall'Era M, Wofsy D.

Curr Opin Rheumatol. 2006 Sep;18(5):476-80. Review.PMID: 16896285 [PubMed - indexed for MEDLINE]Related articles

Systemic sclerosis - continuing progress in developing clinical measures of response.

Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V.

J Rheumatol. 2007 May;34(5):1194-200. Review.PMID: 17477486 [PubMed - indexed for MEDLINE]Related articles

Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease.

Rubin LJ, Black CM, Denton CP, Seibold JR.

Arthritis Res Ther. 2007;9 Suppl 2:S10. Review.PMID: 17767739 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical trials: types, design, and end-points.

Seibold JR.

Curr Opin Rheumatol. 2001 Nov;13(6):512-5. Review.PMID: 11698730 [PubMed - indexed for MEDLINE]Related articles

A standardized core set for systemic sclerosis clinical trials. First step in development of combined response index.

Khanna D.

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v31-2.PMID: 18784137 [PubMed - indexed for MEDLINE]Related articlesFree article

Stem cell transplantation in systemic sclerosis: rationale and status report.

Furst DE, Tyndall A.

Isr Med Assoc J. 2000 Dec;2(12):935-7. Review.PMID: 11344779 [PubMed - indexed for MEDLINE]Related articlesFree article

Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.

Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE; OMERACT 6.

J Rheumatol. 2003 Jul;30(7):1630-47. Review.PMID: 12858472 [PubMed - indexed for MEDLINE]Related articles

Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment.

Villela R, Yuen SY, Pope JE, Baron M; Canadian Scleroderma Research group.

Arthritis Rheum. 2008 May 15;59(5):706-13.PMID: 18438906 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of generalized systemic sclerosis.

Torres MA, Furst DE.

Rheum Dis Clin North Am. 1990 Feb;16(1):217-41. Review.PMID: 2406809 [PubMed - indexed for MEDLINE]Related articles

Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials.

Au K, Khanna D, Clements PJ, Furst DE, Tashkin DP.

Curr Rheumatol Rep. 2009 Apr;11(2):111-9. Review.PMID: 19296883 [PubMed - indexed for MEDLINE]Related articles

Outcome measures in systemic sclerosis: an update on instruments and current research.

Khanna D, Merkel PA.

Curr Rheumatol Rep. 2007 May;9(2):151-7. Review.PMID: 17502046 [PubMed - indexed for MEDLINE]Related articles

Trial design: how must we move ahead?

Seibold JR, Tyndall A, Furst DE.

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v57-8.PMID: 18784148 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of scleroderma.

Gelber AC, Wigley FM.

Curr Opin Rheumatol. 1995 Nov;7(6):551-9. Review.PMID: 8579978 [PubMed - indexed for MEDLINE]Related articles

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors.

Ann Rheum Dis. 2009 May;68(5):620-8. Epub 2009 Jan 15.PMID: 19147617 [PubMed - indexed for MEDLINE]Related articles

Development of a provisional core set of response measures for clinical trials of systemic sclerosis.

Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, Matucci-Cerinic M, Denton CP, Mayes MD, Steen VD, Varga J, Furst DE; Scleroderma Clinical Trials Consortium co-authors.

Ann Rheum Dis. 2008 May;67(5):703-9. Epub 2007 Sep 24.PMID: 17893248 [PubMed - indexed for MEDLINE]Related articles

Endothelin receptor antagonism: role in the treatment of pulmonary arterial hypertension related to scleroderma.

Kabunga P, Coghlan G.

Drugs. 2008;68(12):1635-45. Review.PMID: 18681488 [PubMed - indexed for MEDLINE]Related articles